Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
hb-as02v (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (5 trials)
anti-cd3 conjugated to recombinant ricin a chain (1 trial)
anti-cd7 conjugated to recombinant ricin a chain (1 trial)
ebv vaccine (268664) (1 trial)
autologous hematopoietic stem cells (3 trials)
Graft vs Host Disease (Phase 2)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Trials (10 total)
Trial APIs (6 total)